Friday 4^th February 2011

13:30      Welcome and introduction (C. Sessa, Bellinzona)

13:40      Set the stage: Baseline SWOT analysis of anti-angiogenic therapies in cancer (C. Sessa, Bellinzona)

Mechanisms of angiogenesis with clinical relevance (C. Sessa, Bellinzona)

14:00      Mechanisms of angiogenesis and principles of anti-angiogenic therapies and anti-angiogenic approaches (C. Rüegg, Fribourg)

14:20      Preclinical evidence of evasive resistance to anti-angiogenics (O. Casanovas, Barcelona)

14:40      Discussion

Biomarkers of tumor angiogenesis and response to therapy (M. Reck)

15:00      Definitions, principles, needs (M. Reck)

15:20      Discussion                    

15:35      Coffee break

State of the art in anti-angiogenic treatments I (D. Betticher, Fribourg)

16:00      Colon (R. von Moos, St. Gallen)

16:40      Breast (B. Pestalozzi, Zürich)

17:20      Brain (S. Hofer, Zürich)

18:00      Adjourn

Saturday 5^th February 2011

State of the art in anti-angiogenic treatments II (R. Stahel, Zürich)

08:30      Lung (D. Betticher, Fribourg)

09:20      Ovary (C. Sessa, Bellinzona)

10:10      Wrap up discussion

10:30      Break

Emerging questions and novel prospects (R. Stahel, Zürich)

11:00      Drug combinations (C. Rüegg, Fribourg)

11:20      Treatment duration (C. Sessa, Bellinzona)

11:40      Combination with radiotherapy (O. Riesterer, Zürich)

12:00      Relevance of neo angiogenesis in surgical oncology (N. Demartines, Lausanne)

12:20      Conclusive remarks (C. Sessa, Bellinzona/C. Rüegg, Fribourg)